Modeling predictors and outcomes in myeloproliferative neoplasms and thrombosis
Myeloproliferative neoplasms (MPNs) are characterized by clonal expansion of abnormal hematopoietic stem cells, which...
Prevention
Looking for a reliable tool to identify hypercoagulant markers for cancer risk and prognosis: the HYPERCAN study
The HYPERCAN (HYPERcoagulation in CANcer) study (registered at www.clinicaltrials.gov; NCT02622815) is an ongoing,...
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
The American Society of Clinical Oncology just published the new recommendations regarding VTE prophylaxis and...
Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy
Epidemiology and risk factors Venous thromboembolism (VTE) is a burdensome and frequent complication in patients with...